WO2020032902A3 - Aksolotl blastema for use in the treatment of wounds and burns - Google Patents

Aksolotl blastema for use in the treatment of wounds and burns Download PDF

Info

Publication number
WO2020032902A3
WO2020032902A3 PCT/TR2019/050666 TR2019050666W WO2020032902A3 WO 2020032902 A3 WO2020032902 A3 WO 2020032902A3 TR 2019050666 W TR2019050666 W TR 2019050666W WO 2020032902 A3 WO2020032902 A3 WO 2020032902A3
Authority
WO
WIPO (PCT)
Prior art keywords
blastema
wounds
burns
treatment
aksolotl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/TR2019/050666
Other languages
French (fr)
Other versions
WO2020032902A2 (en
Inventor
Turan DEMIRCAN
Gürkan Öztürk
İlknur KESKİN
Mustafa KESKİN
Hasan ÇELİK
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Istanbul Medipol Universitesi
Original Assignee
Istanbul Medipol Universitesi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Istanbul Medipol Universitesi filed Critical Istanbul Medipol Universitesi
Publication of WO2020032902A2 publication Critical patent/WO2020032902A2/en
Publication of WO2020032902A3 publication Critical patent/WO2020032902A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/65—Amphibians, e.g. toads, frogs, salamanders or newts

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

The present invention relates to the use of axolotl blastema in the treatment of wounds and burns.
PCT/TR2019/050666 2018-08-10 2019-08-08 Aksolotl blastema for use in the treatment of wounds and burns Ceased WO2020032902A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
TR201811635 2018-08-10
TRTR2018/11635 2018-08-10

Publications (2)

Publication Number Publication Date
WO2020032902A2 WO2020032902A2 (en) 2020-02-13
WO2020032902A3 true WO2020032902A3 (en) 2020-04-16

Family

ID=69415969

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/TR2019/050666 Ceased WO2020032902A2 (en) 2018-08-10 2019-08-08 Aksolotl blastema for use in the treatment of wounds and burns

Country Status (1)

Country Link
WO (1) WO2020032902A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025111477A1 (en) * 2023-11-22 2025-05-30 Regenx Science, Inc. Activated amphibian cells and uses thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010136212A1 (en) * 2009-05-29 2010-12-02 Medizinische Hochschule Hannover Lipoxygenase and its use in wound healing

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010136212A1 (en) * 2009-05-29 2010-12-02 Medizinische Hochschule Hannover Lipoxygenase and its use in wound healing

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
DEMIRCAN, TURAN ET AL.: "Axolotl cells and tissues enhances cutaneous wound healing in mice", JOURNAL OF EXPERIMENTAL AND CLINICAL MEDICINE, vol. 33, no. 4, 2016, pages 229 - 237, XP055685887 *

Also Published As

Publication number Publication date
WO2020032902A2 (en) 2020-02-13

Similar Documents

Publication Publication Date Title
MX2022013841A (en) Inhibitors of the menin-mll interaction.
MX2023002982A (en) Inhibitors of the menin-mll interaction.
WO2019032662A8 (en) Clec9a binding agents and use thereof
PH12017501483A1 (en) Bicyclic heterocycles as fgfr4 inhibitors
PH12020552229A1 (en) Il-11ra antibodies
EP4272821A3 (en) Treatment of inflammatory diseases with inhibitors of c5a activity
MX2018007703A (en) Inhibitors of the menin-mll interaction.
MD3240554T2 (en) Blautia stercosis and wexlerae for use in the treatment of inflammatory and autoimmune diseases
EP4610279A3 (en) Compositions and methods of inhibiting masp-3 for the treatment of various diseases and disorders
GEAP202114756A (en) Combination therapy for the treatment of cancer
EP4417262A3 (en) Combination therapy
PH12018501279A1 (en) Compositions comprising 15-hepe and methods of using the same
MX2023010501A (en) Dantrolene prodrugs and methods of their use.
PH12017501980A1 (en) The use of sgc stimulators, sgc activators, alone and combinations with pde5 inhibitors for the treatment of digital ulcers (du) concomitant to systemic sclerosis (ssc)
PH12021550122A1 (en) Solubilized apyrases, methods and use
MX2020000402A (en) Novel substituted xanthine derivatives.
MX2019010218A (en) Pyrazole derivatives as bromodomain inhibitors.
MY200803A (en) Mpo inhibitors for use in medicine
PH12020551331A1 (en) Treatment and prevention of pre-eclampsia
WO2020032902A3 (en) Aksolotl blastema for use in the treatment of wounds and burns
EP4371613A3 (en) Compounds for use in the treatment of ocular pain
WO2019040104A3 (en) Compounds, salts thereof and their use for the treatment of diseases
EP4335508A3 (en) (+)-azasetron for use in the treatment of ear disorders
HK40005766A (en) Topical composition for use in the treatment of burns
HK40005766B (en) Topical composition for use in the treatment of burns

Legal Events

Date Code Title Description
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 19848761

Country of ref document: EP

Kind code of ref document: A2